← Stack analyses
KLOW
SkinComponents
Rationale
A vendor blend (80 mg total: 50 mg GHK-Cu, 10 mg each of KPV/BPC-157/TB-500): a skin copper peptide + anti-inflammatory tripeptide + two 'recovery' peptides in one vial. The logic is 'everything used for skin and recovery at once'.
Evidence level
No study tests this combination. Components individually: GHK-Cu has cosmetic and limited clinical data, KPV and BPC/TB are preclinical. The blend is a marketing concatenation, not an evidence-based formulation.
Caution
Fixed blend ratios lock in dosing: the user cannot adjust individual components. Four peptides at once means four unknown purities. The anti-inflammatory+angiogenic part carries the same theoretical malignancy caveat as the Wolverine stack.